ORIA
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
ORIA
Delisted
ORIA was delisted on the 28th of April, 2023.
48 hedge funds and large institutions have $130M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
48
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$6.41M | |
| 2 | +$2.55M | |
| 3 | +$1.95M | |
| 4 |
TCA
Taconic Capital Advisors
New York
|
+$1.9M |
| 5 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$1.7M |
Top Sellers
| 1 | -$6.41M | |
| 2 | -$2.46M | |
| 3 | -$484K | |
| 4 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$326K |
| 5 |
EAM
Exos Asset Management
New York
|
-$92.5K |